CD8A and neoplasm: Further phenotyping of T cells revealed that C002 tumor treatment increased both CD4(+) T cell frequency and absolute number (Figure 6A), with a concomitant decrease in the CD8(+) frequency (Supplementary Figure 5E), resulting in an increased CD4: CD8 ratio (Supplementary Figure 5F).